SI-Bone Insider Transaction Raises Questions Amid Stock Peak
27.11.2025 - 09:42:04SI-Bone US8257041090
Shares of medical technology firm SI-Bone have surged approximately 55% over the past year, nearly touching their 52-week high of $20.05. This impressive rally, coupled with technical indicators flashing overbought signals, is drawing increased scrutiny from investors. The situation intensified following recent stock sales by a company insider.
Anshul Maheshwari, the Chief Financial Officer of SI-Bone, executed sales of company stock on November 21 and November 25. The transactions involved a total of 1,300 shares sold at prices around $20 per share, generating proceeds of roughly $26,015. This move is particularly notable as the stock was trading close to its annual peak, at $19.49, when the sales occurred. Market technicians point to the Relative Strength Index (RSI) suggesting the Read more...
